Literature DB >> 20600431

Selective toxicity of antimicrobial peptide S-thanatin on bacteria.

Guoqiu Wu1, Hongbin Wu, Xiaobo Fan, Rui Zhao, Xiaofang Li, Shenglan Wang, Yihua Ma, Zilong Shen, Tao Xi.   

Abstract

S-thanatin, an analog of thanatin, was synthesized by substituting the 15th amino acid of threonine with serine, which showed a broad antimicrobial activity against bacteria. We reported earlier that membrane phospholipid was found to be the target for S-thanatin with different mechanism from other antimicrobial peptides. In this study, we have performed its structural characterization by circular dichroism (CD) spectroscopy. The CD analysis showed that S-thanatin retained its overall conformation beta-sheet in aqueous buffer, beta-turn in 50% trifluoroethanol (TFE) and beta-hairpin in 0.4 mM POPC-LUVs. In hemolysis assay, S-thanatin exhibited low hemolytic activity and bacteria selectivity. We investigated the effect of the presence of 33 mol percent cholesterol on the interactions of the antimicrobial peptide S-thanatin with phosphatidylcholine (PC) model membrane systems. The results showed that S-thanatin was more potent at disrupting cholesterol-free bacterial than cholesterol-containing eukaryotic membranes. Thus, in all respects, fluorescence dye leakage experiments indicated that cholesterol inhibited the S-thanatin-induced permeabilization of PC vesicles. Finally, flow cytometry was used to monitor changes in bacterial cell membrane potential and cell membrane integrity, with specific fluorescent dyes DiBAC(4)(3) and PI. Adding the respiratory poison CCCP seemed to prevent peptide-induced membrane damage, which suggested that S-thanatin acted at the metabolic level on respiratory chain. These findings might explain why S-thanatin was selective toxicity towards bacteria, but low toxicity towards erythrocytes. It might be due to three factors at least: electrostatic interaction (namely anionic phospholipids); cholesterol; respiratory chain. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600431     DOI: 10.1016/j.peptides.2010.06.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Does cholesterol play a role in the bacterial selectivity of antimicrobial peptides?

Authors:  Jeffrey R Brender; Austin J McHenry; Ayyalusamy Ramamoorthy
Journal:  Front Immunol       Date:  2012-07-17       Impact factor: 7.561

2.  Paracentrin 1, a synthetic antimicrobial peptide from the sea-urchin Paracentrotus lividus, interferes with staphylococcal and Pseudomonas aeruginosa biofilm formation.

Authors:  Domenico Schillaci; Maria Grazia Cusimano; Angelo Spinello; Giampaolo Barone; Debora Russo; Maria Vitale; Daniela Parrinello; Vincenzo Arizza
Journal:  AMB Express       Date:  2014-10-31       Impact factor: 3.298

Review 3.  Recent Advances on Multi-Parameter Flow Cytometry to Characterize Antimicrobial Treatments.

Authors:  Lucie Léonard; Lynda Bouarab Chibane; Balkis Ouled Bouhedda; Pascal Degraeve; Nadia Oulahal
Journal:  Front Microbiol       Date:  2016-08-08       Impact factor: 5.640

4.  Editorial: In vivo Imaging in Pharmacological Research.

Authors:  Nicolau Beckmann; Igor A Kaltashov; Albert D Windhorst
Journal:  Front Pharmacol       Date:  2017-01-03       Impact factor: 5.810

Review 5.  Guardians of the Gut: Enteric Defensins.

Authors:  Sumathi Sankaran-Walters; Ronald Hart; Chantelle Dills
Journal:  Front Microbiol       Date:  2017-04-19       Impact factor: 5.640

6.  Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.

Authors:  Ejovwoke F Dosunmu; Atul A Chaudhari; Swapnil Bawage; Mona K Bakeer; Donald R Owen; Shree R Singh; Vida A Dennis; Shreekumar R Pillai
Journal:  BMC Microbiol       Date:  2016-08-22       Impact factor: 3.605

7.  S-thanatin functionalized liposome potentially targeting on Klebsiella pneumoniae and its application in sepsis mouse model.

Authors:  Xiaobo Fan; Juxiang Fan; Xiyong Wang; Pengpeng Wu; Guoqiu Wu
Journal:  Front Pharmacol       Date:  2015-10-27       Impact factor: 5.810

Review 8.  Emerging peptide antibiotics with therapeutic potential.

Authors:  Gregory Upert; Anatol Luther; Daniel Obrecht; Philipp Ermert
Journal:  Med Drug Discov       Date:  2020-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.